TG and neoplasm: In the study, measurement of serum CYFRA 21-1 emerged as a valuable substitute biomarker for tumor advancement, particularly in instances where Tg remains undetectable or unmonitored due to the presence of Tg antibodies (TgAb) or in poorly differentiated thyroid carcinoma.